Enoxaparin Sodium

Enoxaparin Sodium (IP/BP/USP)


Enoxaparin is an anticoagulant, also known as a “blood thinner.” It is a type of heparin. Enoxaparin belongs to the class of drugs known as low molecular weight heparins. Enoxaparin binds to and accelerates the activity of antithrombin III. By activating antithrombin III, enoxaparin preferentially potentiates the inhibition of coagulation factors Xa and IIa. Factor Xa catalyzes the conversion of prothrombin to thrombin, so enoxaparin’s inhibition of this process results in decreased thrombin and ultimately the prevention of fibrin clot formation. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.

Enoxaparin Sodium is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Other uses include inside kidney dialysis machines.

Bactochem Plant Capacity:
1200 kgs

Grade:
Injectable

Specification:
BP/EP/USP/IP

Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina.

Enoxaparin Sodium Injection is indicated for:

  • Treatment of unstable angina (UA) and non-Q-wave myocardial infarction (NQMI), administered concurrently with aspirin
  • DVT prophylaxis in knee replacement surgery
  • DVT prophylaxis in hip replacement surgery
  • DVT prophylaxis in abdominal surgery
  • Treatment of DVT with or without pulmonary embolism
  • Treatment of DVT inpatient, with ST-segment elevation myocardial infarction (STEMI)

Structure of Enoxaparin Sodium